HUBS vs ORMP
HubSpot Inc (HUBS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported HUBS revenue for 2024-12-31 was $2.63B. Net income was $4.6M. Revenue was up 21.1% from 2023-12-31 to 2024-12-31. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the HUBS and ORMP stock pages for the full models.
Not investment advice.